Financial Ratios Netcare Limited Johannesburg S.E.
Stocks
NTCP
ZAE000081121
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.00 ZAR | 0.00% |
|
+1.09% | -3.30% |
| 05-25 | Netcare Limited, H1 2026 Earnings Call, May 25, 2026 | |
| 05-25 | Netcare Limited Reports Earnings Results for the Half Year Ended March 31, 2026 | CI |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.07 | 5.39 | 6.42 | 6.89 | 7.63 | |||||
Return on Total Capital | 6.06 | 6.46 | 7.69 | 8.24 | 9.24 | |||||
Return On Equity % | 7.46 | 9.75 | 12.15 | 14.06 | 16.48 | |||||
Return on Common Equity | 7.66 | 9.66 | 12.19 | 13.67 | 16.14 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 49.3 | 48.77 | 49.63 | 49.42 | 49.7 | |||||
SG&A Margin | 40.1 | 39.61 | 39.28 | 38.49 | 38.33 | |||||
EBITDA Margin % | 13.55 | 13.81 | 15.12 | 15.57 | 16.49 | |||||
EBITA Margin % | 9.87 | 10.35 | 11.74 | 12.3 | 13.36 | |||||
EBIT Margin % | 9.87 | 10.34 | 11.73 | 12.28 | 13.35 | |||||
Income From Continuing Operations Margin % | 3.58 | 4.85 | 5.64 | 6.14 | 6.87 | |||||
Net Income Margin % | 3.63 | 4.68 | 5.57 | 5.95 | 6.62 | |||||
Net Avail. For Common Margin % | 3.44 | 4.51 | 5.3 | 5.6 | 6.29 | |||||
Normalized Net Income Margin | 3.72 | 4.29 | 5.11 | 5.11 | 5.79 | |||||
Levered Free Cash Flow Margin | 5.26 | 5.76 | 3.72 | 3.69 | 6.43 | |||||
Unlevered Free Cash Flow Margin | 7.75 | 8.15 | 6.37 | 6.68 | 9.18 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.82 | 0.83 | 0.88 | 0.9 | 0.91 | |||||
Fixed Assets Turnover | 1.29 | 1.28 | 1.35 | 1.37 | 1.38 | |||||
Receivables Turnover (Average Receivables) | 6.67 | 7.66 | 7.4 | 7.77 | 7.72 | |||||
Inventory Turnover (Average Inventory) | 11.64 | 18.44 | 21.35 | 23.05 | 24.77 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1 | 1.03 | 1.15 | 1.02 | 1.15 | |||||
Quick Ratio | 0.86 | 0.89 | 1.04 | 0.91 | 1.02 | |||||
Operating Cash Flow to Current Liabilities | 0.41 | 0.49 | 0.48 | 0.43 | 0.6 | |||||
Days Sales Outstanding (Average Receivables) | 54.69 | 47.67 | 49.32 | 47.07 | 47.29 | |||||
Days Outstanding Inventory (Average Inventory) | 31.34 | 19.79 | 17.09 | 15.88 | 14.74 | |||||
Average Days Payable Outstanding | 115.38 | 39.79 | 39.97 | 37.29 | 38.47 | |||||
Cash Conversion Cycle (Average Days) | -29.34 | 27.66 | 26.45 | 25.67 | 23.56 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 102.78 | 99.26 | 111.39 | 115.28 | 117.99 | |||||
Total Debt / Total Capital | 50.68 | 49.81 | 52.69 | 53.55 | 54.13 | |||||
LT Debt/Equity | 80.5 | 83.8 | 94.11 | 94.01 | 106.22 | |||||
Long-Term Debt / Total Capital | 39.7 | 42.06 | 44.52 | 43.67 | 48.73 | |||||
Total Liabilities / Total Assets | 58.67 | 58.34 | 60.29 | 61.35 | 62.4 | |||||
EBIT / Interest Expense | 2.48 | 2.7 | 2.77 | 2.57 | 3.03 | |||||
EBITDA / Interest Expense | 3.85 | 4.1 | 4 | 3.64 | 4.15 | |||||
(EBITDA - Capex) / Interest Expense | 2.51 | 2.43 | 2.56 | 2.43 | 2.85 | |||||
Total Debt / EBITDA | 3.35 | 3.2 | 3.07 | 2.88 | 2.69 | |||||
Net Debt / EBITDA | 2.9 | 2.76 | 2.49 | 2.47 | 2.3 | |||||
Total Debt / (EBITDA - Capex) | 5.14 | 5.39 | 4.79 | 4.32 | 3.92 | |||||
Net Debt / (EBITDA - Capex) | 4.45 | 4.64 | 3.9 | 3.7 | 3.35 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 12.51 | 2.06 | 9.54 | 6.34 | 4.53 | |||||
Gross Profit, 1 Yr. Growth % | 15.71 | 0.95 | 11.48 | 6.14 | 5.12 | |||||
EBITDA, 1 Yr. Growth % | 34.65 | 4.7 | 19.91 | 13.5 | 10.68 | |||||
EBITA, 1 Yr. Growth % | 55.27 | 6.92 | 24.24 | 16.59 | 13.58 | |||||
EBIT, 1 Yr. Growth % | 55.27 | 6.88 | 24.23 | 16.65 | 13.6 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 73.12 | 38.16 | 27.24 | 15.79 | 17 | |||||
Net Income, 1 Yr. Growth % | 72.42 | 31.73 | 30.4 | 13.47 | 16.28 | |||||
Normalized Net Income, 1 Yr. Growth % | 121.57 | 17.6 | 30.5 | 13.63 | 18.46 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 93.24 | 32.04 | 30.4 | 16.47 | 22.04 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.8 | 2.69 | 23.72 | 13.33 | -1.77 | |||||
Inventory, 1 Yr. Growth % | -46.93 | -12.19 | -1.07 | -1.08 | -5.45 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.58 | 4.38 | 4.18 | 4.85 | 2.58 | |||||
Total Assets, 1 Yr. Growth % | -1.24 | 2.53 | 5.84 | 2.11 | 2.94 | |||||
Tangible Book Value, 1 Yr. Growth % | 11.04 | 2.69 | 1.75 | -1.33 | -3.5 | |||||
Common Equity, 1 Yr. Growth % | 8.88 | 3.15 | 1.27 | -0.84 | -0.6 | |||||
Cash From Operations, 1 Yr. Growth % | -1.85K | 13.32 | 2.91 | 1.15 | 25.19 | |||||
Capital Expenditures, 1 Yr. Growth % | 17.79 | 22.08 | 4.41 | 1.39 | 2.73 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -678.84 | 9.26 | -29.2 | 15.42 | 82.2 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 281.68 | 5.69 | -14.47 | 17.63 | 43.68 | |||||
Dividend Per Share, 1 Yr. Growth % | - | 47.06 | 30 | 7.69 | 21.43 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -0.9 | 7.16 | 5.73 | 7.93 | 5.43 | |||||
Gross Profit, 2 Yr. CAGR % | -2.24 | 8.08 | 6.08 | 8.65 | 5.63 | |||||
EBITDA, 2 Yr. CAGR % | -19.71 | 18.36 | 12.05 | 14.61 | 12.08 | |||||
EBITA, 2 Yr. CAGR % | -24.97 | 28.91 | 15.26 | 17.62 | 15.08 | |||||
EBIT, 2 Yr. CAGR % | -24.95 | 28.82 | 15.23 | 17.64 | 15.12 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -44.62 | 54.65 | 32.59 | 21.38 | 16.4 | |||||
Net Income, 2 Yr. CAGR % | -43.94 | 50.71 | 31.07 | 21.65 | 14.87 | |||||
Normalized Net Income, 2 Yr. CAGR % | -39.33 | 61.42 | 23.88 | 17.78 | 16.02 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -44.3 | 59.74 | 31.22 | 23.24 | 19.22 | |||||
Accounts Receivable, 2 Yr. CAGR % | 17.57 | -3.93 | 12.71 | 9.68 | 5.51 | |||||
Inventory, 2 Yr. CAGR % | 6.52 | -31.74 | -6.79 | -1.07 | -3.29 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 14.76 | 2.46 | 4.28 | 4.52 | 3.71 | |||||
Total Assets, 2 Yr. CAGR % | 9.38 | 0.63 | 4.17 | 3.96 | 2.53 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.94 | 7.35 | 2.22 | 0.2 | -2.42 | |||||
Common Equity, 2 Yr. CAGR % | 2.04 | 5.98 | 2.21 | 0.21 | -0.72 | |||||
Cash From Operations, 2 Yr. CAGR % | -15.37 | 344.84 | 7.99 | 2.03 | 12.53 | |||||
Capital Expenditures, 2 Yr. CAGR % | -9.36 | 19.92 | 12.9 | 2.89 | 2.06 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -20.56 | 154.4 | -12.05 | -13.66 | 45.02 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -12.45 | 102.43 | -4.92 | -2.33 | 30 | |||||
Dividend Per Share, 2 Yr. CAGR % | -44.66 | - | 38.27 | 18.32 | 14.35 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 0.77 | 0.07 | 7.94 | 5.93 | 6.78 | |||||
Gross Profit, 3 Yr. CAGR % | 0.32 | -1.19 | 9.2 | 6.02 | 7.46 | |||||
EBITDA, 3 Yr. CAGR % | -13.02 | -12.47 | 18.87 | 11.21 | 13.28 | |||||
EBITA, 3 Yr. CAGR % | -15.34 | -15.54 | 27.33 | 13.94 | 16.26 | |||||
EBIT, 3 Yr. CAGR % | -15.3 | -15.56 | 27.27 | 13.94 | 16.28 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -8.92 | -24.89 | 44.92 | 26.73 | 19.9 | |||||
Net Income, 3 Yr. CAGR % | -46.21 | -25.47 | 43.61 | 24.92 | 19.83 | |||||
Normalized Net Income, 3 Yr. CAGR % | -29.16 | -24.35 | 50.38 | 17.72 | 18.01 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -12.96 | -25.73 | 49.29 | 26.11 | 22.84 | |||||
Accounts Receivable, 3 Yr. CAGR % | 12.62 | 6.77 | 4.52 | 7.3 | 5.72 | |||||
Inventory, 3 Yr. CAGR % | 2.81 | -0.12 | -22.75 | -4.93 | -2.56 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 10.93 | 11.19 | 3.03 | 4.47 | 3.87 | |||||
Total Assets, 3 Yr. CAGR % | 7.26 | 7.05 | 2.33 | 3.48 | 3.62 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.49 | 2.55 | 5.45 | 1.02 | -1.05 | |||||
Common Equity, 3 Yr. CAGR % | 0.72 | 2.41 | 4.38 | 1.18 | -0.06 | |||||
Cash From Operations, 3 Yr. CAGR % | -2.45 | -6.72 | 173.08 | 5.66 | 9.23 | |||||
Capital Expenditures, 3 Yr. CAGR % | -9.2 | 0.1 | 14.51 | 8.93 | 2.84 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 70.58 | -10.97 | 66.09 | -6.61 | 10.74 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 42.56 | -6.29 | 51.9 | 0.28 | 11.08 | |||||
Dividend Per Share, 3 Yr. CAGR % | -31.11 | -23.34 | - | 27.22 | 19.35 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -10.89 | 2.51 | 2.73 | 3.14 | 6.93 | |||||
Gross Profit, 5 Yr. CAGR % | -8.66 | 2.22 | 2.58 | 2.64 | 7.71 | |||||
EBITDA, 5 Yr. CAGR % | -11.61 | -7.91 | -3.87 | -2.5 | 15.29 | |||||
EBITA, 5 Yr. CAGR % | -12.3 | -7.43 | -4.2 | -3.58 | 21.16 | |||||
EBIT, 5 Yr. CAGR % | -12.28 | -7.44 | -4.21 | -3.58 | 21.14 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -5.97 | -16.18 | 5.84 | -8.99 | 32.75 | |||||
Net Income, 5 Yr. CAGR % | -14.86 | 15.49 | -23.19 | -9.34 | 31.34 | |||||
Normalized Net Income, 5 Yr. CAGR % | -15.53 | -26.35 | -11.41 | -9.7 | 33.76 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -14.61 | -26.85 | 2.58 | -9.05 | 36.45 | |||||
Accounts Receivable, 5 Yr. CAGR % | -2.28 | -3.39 | 9.25 | 7.93 | 1.75 | |||||
Inventory, 5 Yr. CAGR % | -8.88 | -10.6 | -1.15 | -0.5 | -15.49 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 2.75 | 4.39 | 8.22 | 8.47 | 3.3 | |||||
Total Assets, 5 Yr. CAGR % | -3.53 | -1.35 | 6.01 | 5.8 | 2.41 | |||||
Tangible Book Value, 5 Yr. CAGR % | 6.43 | 6.1 | 1.4 | 1.6 | 2.23 | |||||
Common Equity, 5 Yr. CAGR % | -0.48 | 4.35 | 1.31 | 1.53 | 2.31 | |||||
Cash From Operations, 5 Yr. CAGR % | -8.11 | 0.71 | 1.6 | -3.31 | 91.55 | |||||
Capital Expenditures, 5 Yr. CAGR % | -16.5 | -10.59 | -0.93 | 1.2 | 9.36 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 12.86 | 4.57 | 31.48 | -12.06 | 54.45 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 9.75 | 6.66 | 21.62 | -4.72 | 41.22 | |||||
Dividend Per Share, 5 Yr. CAGR % | -18.58 | -12.05 | -8.97 | -8.81 | - |
- Stock Market
- Stocks
- NTC Stock
- NTCP Stock
- Financials Netcare Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















